RACK1 is required for normal B cell development and signaling but not RAG1 degradation
- PMID: 40849887
- PMCID: PMC12380162
- DOI: 10.1093/jimmun/vkaf217
RACK1 is required for normal B cell development and signaling but not RAG1 degradation
Abstract
V(D)J recombination is constrained by timely degradation of the RAG1 and RAG2 proteins through distinct mechanisms. Previously, we showed that full-length RAG1 stability is regulated by viral protein R binding protein (VprBP) through its association with an amino-terminal region in RAG1, but the mechanism remains unclear. As an unbiased approach to uncover potential cofactors involved in the process, we compared protein interactomes between RAG1/RAG2 complexes formed when the amino-terminal third of RAG1 was present or absent. These experiments identified RACK1 as preferentially associating with full-length RAG1. Because RACK1 is implicated in mediating protein degradation in other contexts, we evaluated how loss of RACK1 in B cells affects B cell development and V(D)J recombination. We find that conditional disruption of Rack1 expression in the B lineage in mice blocks B cell development at the pro-B cell stage and impairs V(D)J recombination after Igh DH-JH rearrangement. In this background, enforced Bcl2 expression does not significantly rescue B cell development but does enable the V(D)J recombination defect to be bypassed. However, the phenotype of these mice does not show the excessive Igk rearrangement, skewing toward Igλ+ B cells, or increased RAG1 protein levels observed when VprBP expression is similarly disrupted in B cells, arguing against RACK1 serving as a cofactor in RAG1 degradation. Further studies provide evidence that loss of RACK1 in primary B cells dysregulates cell cycle progression, apoptosis, proliferation, and signaling through MAPK and NF-κB pathways.
Keywords: B cell development; B cell signaling; RACK1; Src kinase; V(D)J recombination.
© The Author(s) 2025. Published by Oxford University Press on behalf of The American Association of Immunologists. All rights reserved. For commercial re-use, please contact reprints@oup.com for reprints and translation rights for reprints. All other permissions can be obtained through our RightsLink service via the Permissions link on the article page on our site—for further information please contact journals.permissions@oup.com.
Conflict of interest statement
Disclosures
The authors declare no financial conflicts of interest.
Similar articles
-
Prescription of Controlled Substances: Benefits and Risks.2025 Jul 6. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. 2025 Jul 6. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. PMID: 30726003 Free Books & Documents.
-
How RAG1/2 evolved from ancestral transposases to initiate V(D)J recombination without transposition.Proc Natl Acad Sci U S A. 2025 Aug 5;122(31):e2512362122. doi: 10.1073/pnas.2512362122. Epub 2025 Jul 29. Proc Natl Acad Sci U S A. 2025. PMID: 40729386
-
How RAG1/2 evolved from ancestral transposases to initiate V(D)J recombination without transposition.Res Sq [Preprint]. 2025 Feb 12:rs.3.rs-5443361. doi: 10.21203/rs.3.rs-5443361/v1. Res Sq. 2025. Update in: Proc Natl Acad Sci U S A. 2025 Aug 5;122(31):e2512362122. doi: 10.1073/pnas.2512362122. PMID: 39989977 Free PMC article. Updated. Preprint.
-
The Black Book of Psychotropic Dosing and Monitoring.Psychopharmacol Bull. 2024 Jul 8;54(3):8-59. Psychopharmacol Bull. 2024. PMID: 38993656 Free PMC article. Review.
-
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.Cochrane Database Syst Rev. 2020 Jan 9;1(1):CD011535. doi: 10.1002/14651858.CD011535.pub3. Cochrane Database Syst Rev. 2020. Update in: Cochrane Database Syst Rev. 2021 Apr 19;4:CD011535. doi: 10.1002/14651858.CD011535.pub4. PMID: 31917873 Free PMC article. Updated.
References
-
- Schatz DG, and Swanson PC. 2011. V(D)J Recombination: Mechanisms of Initiation. Annual Review Genetics, Vol 45 45: 167–202. - PubMed
-
- Schatz DG, Oettinger MA, and Baltimore D. 1989. The V(D)J recombination activating gene, RAG-1. Cell 59: 1035–1048. - PubMed
-
- Oettinger MA, Schatz DG, Gorka C, and Baltimore D. 1990. RAG-1 and RAG-2, adjacent genes that synergistically activate V(D)J recombination. Science 248: 1517–1523. - PubMed
-
- Marculescu R, Vanura K, Montpellier B, Roulland S, Le T, Navarro JM, Jager U, McBlane F, and Nadel B. 2006. Recombinase, chromosomal translocations and lymphoid neoplasia: targeting mistakes and repair failures. DNA Repair (Amst) 5: 1246–1258. - PubMed
-
- Kuppers R, and Dalla-Favera R. 2001. Mechanisms of chromosomal translocations in B cell lymphomas. Oncogene 20: 5580–5594. - PubMed
Grants and funding
- P20 GM139762/GM/NIGMS NIH HHS/United States
- National Institute of General Medical Science
- NIH
- GM102487-03S1/Bio-Rad ZE5 Cell Analyzer
- C06 RR17417-01/GF/NIH HHS/United States
- Nebraska Department of Health and Human Services
- GM139762/University of Nebraska Medical Center
- Boys Town National Research Hospital
- G20RR024001/Creighton University Animal Resource Facility
- SCR_023866/Auditory and Vestibular Technology Core Facility
- R21 AI153688/AI/NIAID NIH HHS/United States
- Creighton University
- R01 GM102487/GM/NIGMS NIH HHS/United States
- State of Nebraska
- G20 RR024001/RR/NCRR NIH HHS/United States
- Flow Cytometry Core Facility
- 1R21AI153688/NH/NIH HHS/United States
- GM139762-04S1/Invitrogen Bigfoot
- Auditory and Vestibular Technology Core Facility
- C06 RR017417/RR/NCRR NIH HHS/United States
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous